TABLE 1.
Isolate group | No. of isolates | Three-dimensional test result for AmpC detectiona | Double-disk test result for ESBL detection | Double-disk test result for MBL detection | NCCLS confirmatory test result for ESBLs
|
||
---|---|---|---|---|---|---|---|
Zone diameter change on CAZ (mm)b | Zone diameter change on CTX (mm)b | No. (%) of test-positive isolates | |||||
1a | 30 | Positive | Negative | Negative | +1 to +4 | 0 to +1 | 0 (0) |
1b | 12 | Positive | Negative | Negative | −4 to −8 | 0 to −5 | 0 (0) |
2a | 10 | Positive | Positive | Negative | −2 to −4 | +8 to +14 | 9 (100) |
2b | 6 | Positive | Positive | Negative | +1 to +3 | +12 to +14 | 5 (100) |
2c | 19 | Positive | Positive | Negative | +1 to +5 | +2 to +6 | 9 (47.4) |
3 | 2 | Positive | Negative | Positive | +4, +6 | +2, +4 | 1 (50.0) |
4 | 9 | Negative or indeterminate | Positive | Negative | +6 to +17 | +7 to +14 | 9 (100) |
5 | 11 | Negative or indeterminate | Negative | Negative | +1 to +3 | +1 to +3 | 11 (0) |
The results were interpreted and grouped as described by Manchanda and Singh (7).
Changes in zone diameters of disks of ceftazidime (CAZ) and cefotaxime (CTX) plus clavulanic acid in comparison with those of drug disks-without clavulanic acid.